Stock futures hovered near the flatline on Tuesday evening, as investors looked toward a key earnings report from tech giant ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Incyte (INCY – Research Report) yesterday and set a price target of $74.00. The ...

Two Arlington defense tech firms are joining up through an all-stock deal with an enterprise value of roughly $4.1 billion.

Shares of Imperial Brands (LON: IMB) rose on Tuesday after the tobacco and next-generation products (NGP) company posted ...

In a report released today, Gregory Renza from RBC Capital maintained a Buy rating on Perspective Therapeutics (CATX – Research Report). The company’s shares closed yesterday at $6.96. Don't Miss our ...

The Dow Jones Industrial Average went down 55.39 points or 0.1% to end at 43,389.60 for its third straight daily loss, ...

Tariffs have taken the spotlight as a policy issue as S&P 500 companies have discussed earnings with analysts since the U.S.

Stocks rebounded after last week’s slide as a rout in Treasuries abated after 10-year yields approached 4.5%, with traders keeping a close eye on news around President-elect Donald Trump’s ...

Rathbones Asset Management has expanded its multi-asset team with the hire of equity research analyst Emma Letheren.

Trump is reported to be developing a framework for AVs. Here's what analysts think about how AVs could boost Tesla's stock.

On Friday, Aramark (ARMK) stock saw a decline, ending the day at $37.36 which represents a decrease of $-1.32 or -3.41% from the prior close of $38.68. The stock opened at $38.68 and touched a low of ...

Teslas stock received a major boost on Friday as RBC Capital raised its price target to $387, up from $323, citing increased ...